ClinicalTrials.Veeva

Menu

Ketoacid Analogues Intradialytic Effect on Inflammation

R

RSUP Fatmawati

Status

Not yet enrolling

Conditions

Hemodialysis Complication

Treatments

Drug: Ketoacid

Study type

Interventional

Funder types

Other

Identifiers

NCT06392516
RSF_IPDGH_01

Details and patient eligibility

About

this study tries to measure the effect of intradialytic ketoacid analogues on inflammatory parameters

Full description

this study will measure inflammation parameters:

  • interleukin 6
  • malnutrition inflammation score
  • neutrophil lymphocyte ratio
  • monocyte lymphocyte ratio
  • thrombocyte lymphocyte ratio

the duration of intervention is 12 weeks

Enrollment

86 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patient who undergo hemodialysis two times a week

Exclusion criteria

  • travelling hemodialysis
  • acute conditions
  • HIV patient
  • acute infection
  • stroke and immobilized patient

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

86 participants in 2 patient groups

control
No Intervention group
Description:
patient who undergo hemodialysis two times a week
intervention
Experimental group
Description:
will be given parenteral ketoacid analogues intradialytics two times a week
Treatment:
Drug: Ketoacid

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems